190 related items for PubMed ID: 8039271
1. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ, Jackson RV, Grice JE, Hockings GI, Crosbie GV, Walters MM.
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
[Abstract] [Full Text] [Related]
2. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
Clin Exp Pharmacol Physiol; 1995 Feb; 22(6-7):441-3. PubMed ID: 8582096
[Abstract] [Full Text] [Related]
3. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[Abstract] [Full Text] [Related]
4. Aspirin increases the human hypothalamic-pituitary-adrenal axis response to naloxone stimulation.
Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson AJ, Jackson RV.
J Clin Endocrinol Metab; 1993 Aug; 77(2):404-8. PubMed ID: 8393884
[Abstract] [Full Text] [Related]
5. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
[Abstract] [Full Text] [Related]
6. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ, Ellis MJ, Evans MJ, Donald RA.
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[Abstract] [Full Text] [Related]
7. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV.
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[Abstract] [Full Text] [Related]
8. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
[Abstract] [Full Text] [Related]
9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI, Ferries LM, Roberts B, Qualls CR, Veldhuis JD, Lisansky EJ.
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[Abstract] [Full Text] [Related]
10. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
Clark DJ, Lipworth BJ.
Chest; 1997 Nov 05; 112(5):1248-52. PubMed ID: 9367464
[Abstract] [Full Text] [Related]
11. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
Hohnloser J, Von Werder K, Müller OA.
Clin Endocrinol (Oxf); 1989 Aug 05; 31(2):175-84. PubMed ID: 2557988
[Abstract] [Full Text] [Related]
12. Interactions between the stimulated hypothalamic-pituitary-adrenal axis and leptin in humans.
Nye EJ, Bornstein SR, Grice JE, Tauchnitz R, Hockings GI, Strakosch CR, Jackson RV, Torpy DJ.
J Neuroendocrinol; 2000 Feb 05; 12(2):141-5. PubMed ID: 10718909
[Abstract] [Full Text] [Related]
13. Effect of naproxen on the hypothalamic-pituitary-adrenal axis in healthy volunteers.
Eijsbouts AM, Kempers MJ, Kramer RS, Hopman MT, van den Hoogen FH, Laan RF, Hermus AR, Sweep FC, van de Putte LB.
Br J Clin Pharmacol; 2009 Jan 05; 67(1):22-8. PubMed ID: 19133058
[Abstract] [Full Text] [Related]
14. Social setting, social rank and HPA axis response in cynomolgus monkeys.
Jimenez VA, Allen DC, McClintick MN, Grant KA.
Psychopharmacology (Berl); 2017 Jun 05; 234(12):1881-1889. PubMed ID: 28332004
[Abstract] [Full Text] [Related]
15. Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy.
Buyalos RP, Jackson RV, Grice GI, Hockings GI, Torpy DJ, Fox LM, Boots LR, Azziz R.
J Clin Endocrinol Metab; 1998 Sep 05; 83(9):3219-24. PubMed ID: 9745431
[Abstract] [Full Text] [Related]
16. Exogenous opioid regulation of the hypothalamic-pituitary-adrenal axis in fetal sheep.
Brooks AN, Challis JR.
J Endocrinol; 1988 Dec 05; 119(3):389-95. PubMed ID: 2851636
[Abstract] [Full Text] [Related]
17. Altered hypothalamic-pituitary-adrenal axis responsiveness in myotonic dystrophy: in vivo evidence for abnormal dihydropyridine-insensitive calcium transport.
Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson RV.
J Clin Endocrinol Metab; 1993 Jun 05; 76(6):1433-8. PubMed ID: 8388880
[Abstract] [Full Text] [Related]
18. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV, Jackson RV.
J Clin Endocrinol Metab; 1994 Jul 05; 79(1):140-4. PubMed ID: 8027217
[Abstract] [Full Text] [Related]
19. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
Lanzone A, Guido M, Ciampelli M, Fulghesu AM, Pavone V, Proto C, Caruso A, Mancuso S.
Clin Endocrinol (Oxf); 1996 Jul 05; 45(1):73-7. PubMed ID: 8796141
[Abstract] [Full Text] [Related]
20. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
Crit Care Med; 2001 Feb 05; 29(2):310-6. PubMed ID: 11246311
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
